Immunoexpression of CDX2 in metastatic nonintestinal adenocarcinomas: an immunohistochemical pitfall and its pathological implications
Abstract Background CDX2, a homeobox gene is the marker of intestinal differentiation. Its expression may lead to misdiagnosis while evaluating metastasis from unknown primary. In the present narrative, we discuss the clinical, morphological, and immunohistochemical (IHC) findings of metastatic aden...
Saved in:
Main Authors: | Krachi Agarwal (Author), Preeti Agarwal (Author), Shipra Singh (Author), Mili Jain (Author), Sumaira Qayoom (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CDX2 positivity in metastatic endometrial carcinoma to the lung: A diagnostic pitfall
by: Kedar K Deodhar, et al.
Published: (2011) -
Aberrant CDX2 expression and metastatic endometrial adenocarcinoma to the lung
by: Antonio D'Antonio
Published: (2011) -
MUC1, MUC2, MUC4, MUC5AC, Cdx2: immunohistochemical characteristics in polyps and adenocarcinoma of distal colon
by: M. A. Shyshkin
Published: (2019) -
Expression of CDX-2 and Ki-67 in different grades of colorectal adenocarcinomas
by: Anway Sen, et al.
Published: (2015) -
The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody
by: Bayrak Reyhan, et al.
Published: (2012)